Basel Medical Group Ltd Ordinary Shares (BMGL) Stock

Basel Medical Group Ltd Ordinary Shares (BMGL) is a Healthcare stock trading at $4.58 (as of 2026-08-25), with a market capitalization of $9.24M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Understand Basel Medical Group Ltd Ordinary Shares: how it makes money

Basel Medical Group provides healthcare services and earns revenue from delivering those services.

The model depends on healthcare-service revenue being sufficient to cover the costs of delivering care.

Business quality (Weak): Business quality is rated Weak, and reported ROE was -196.0% for the fiscal period ended June 30, 2025.

Valuation — source: SEC EDGAR (first-party)
Price$4.58
Market Cap$9.24M
Price / Book1.70
Price / Sales0.82
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$11.32M
Net Margin-94.0%
Return on Equity-222.3%
Debt / Equity0.54
Current Ratio1.31
Revenue Growth (YoY)12.6%
EPS Growth (YoY)-446.2%
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.9
Industry P/E (Healthcare Services)25.4
Company
SectorHealthcare
IndustryHealthcare Services

Related Companies (Healthcare Services; 8 comparable companies)

  • AirSculpt Technologies, Inc. (AIRS)
  • SBC Medical Group Holdings Incorporated (SBC)
  • LifeMD, Inc. (LFMD)
  • Cryo-Cell International, Inc. (CCEL)
  • Strata Critical Medical, Inc. (SRTA)
  • Talkspace, Inc. (TALK)
  • Park Dental Partners, Inc. Common Stock (PARK)
  • Celcuity Inc. (CELC)
BMGL earnings history · BMGL institutional & insider holders · BMGL KPIs & operating metrics · BMGL financials · BMGL investor presentations & press releases · BMGL SEC filings · BMGL peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-25.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.